NPI: 1982798831 · DOWNEY, CA 90241 · Obstetrics & Gynecology Physician · NPI assigned 10/03/2006
Authorized official FELDKAMP IV, IRVING controls 20+ related entities in our dataset. Read more
| Authorized Official | FELDKAMP IV, IRVING (OWNER) |
| NPI Enumeration Date | 10/03/2006 |
Other providers sharing the same authorized official: FELDKAMP IV, IRVING
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 30,663 | $3.34M |
| 2019 | 19,833 | $1.87M |
| 2020 | 8,663 | $575K |
| 2021 | 11,255 | $923K |
| 2022 | 12,939 | $1.18M |
| 2023 | 16,630 | $1.47M |
| 2024 | 13,164 | $971K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 2,294 | 2,068 | $2.60M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 20,759 | 18,822 | $1.34M |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 1,371 | 1,061 | $1.11M |
| J3490 | Unclassified drugs | 18,961 | 16,454 | $1.01M |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 2,411 | 2,338 | $757K |
| S4993 | Contraceptive pills for birth control | 3,576 | 3,562 | $491K |
| A4267 | Contraceptive supply, condom, male, each | 19,776 | 19,629 | $388K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 3,201 | 2,964 | $370K |
| 58300 | 3,877 | 1,968 | $346K | |
| 11981 | 1,608 | 1,604 | $341K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4,003 | 3,944 | $180K |
| 90651 | 795 | 790 | $166K | |
| J7300 | Intrauterine copper contraceptive (paragard) | 228 | 200 | $161K |
| J7296 | Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg | 161 | 159 | $136K |
| 11976 | 2,248 | 1,141 | $119K | |
| 59840 | 715 | 444 | $111K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,743 | 1,653 | $104K |
| G9920 | Screening performed and negative | 2,820 | 2,811 | $76K |
| 58301 | 2,299 | 1,186 | $74K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 2,595 | 2,373 | $68K |
| S0190 | Mifepristone, oral, 200 mg | 1,525 | 1,520 | $61K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,167 | 812 | $59K |
| 99000 | 5,080 | 5,071 | $41K | |
| 76830 | Ultrasound, transvaginal | 482 | 480 | $30K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 2,304 | 2,304 | $29K |
| S0191 | Misoprostol, oral, 200 mcg | 1,650 | 1,640 | $23K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 732 | 728 | $23K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 732 | 729 | $19K |
| 99201 | 182 | 133 | $16K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 95 | 95 | $15K |
| J7301 | Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg | 22 | 12 | $14K |
| 01966 | 381 | 378 | $14K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 260 | 253 | $13K |
| 57454 | 140 | 71 | $8K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 238 | 237 | $7K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 1,062 | 1,048 | $4K |
| 86592 | 751 | 750 | $3K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 73 | 71 | $3K |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 251 | 245 | $3K |
| 83986 | 340 | 339 | $1K | |
| 57061 | 28 | 12 | $951.76 | |
| 87481 | 24 | 24 | $792.23 | |
| 87799 | 24 | 24 | $723.52 | |
| 85018 | 95 | 94 | $637.83 | |
| 81025 | 56 | 53 | $198.02 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 12 | 12 | $40.46 |